Institutional Review Board approval was obtained for this study.
TPS was calculated as Class 1 (optimal, trivial or no residua), Class 2 (adequate, minor residua), or Class 3 (inadequate, major residua, or pre-discharge reintervention for major residua) based on echocardiographic and clinical findings at discharge. Hospital costs for each admission were calculated using costto-charge ratio standardized to 2013 U.S. dollars to account for inflation.
A generalized linear model assuming a gamma distribution with a log link was used to examine the relationship between technical performance score and total hospital costs, adjusting for baseline patient risk using RACHS-1 (Risk Adjustment in Congenital Heart Surgery) and PRECISE (Pediatric Resource Expenditure in Cardiac Specialty Encounters) methods of risk adjustment. Analyses were repeated summing hospital costs for the surgical admission plus all additional costs incurred during the 2 years post-discharge. SAS version 9.4 (SAS Institute, Cary, North Carolina) was utilized for statistical analysis.
There were a total of 1,730 consecutive unique patients meeting inclusion criteria in our cohort.
The median total hospital costs for the index operation adjusted to the year 2013 costs across TPS classes as well as adjusted cost increases for hospital admission and 2-year follow-up are shown in Table 1 .
After adjusting for baseline patient risk, inadequate TPS remained significantly associated with higher cost (increase by factor of 2.48, p < 0.001) ( 
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